Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia

BACKGROUND: The relevance of recurrent molecular abnormalities in cytogenetically normal (CN) acute myeloid leukemia (AML) was recently acknowledged by the inclusion of molecular markers such as NPM1, FLT3, and CEBPA as a complement to cytogenetic information within both the World Health Organizatio...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Yang, Wen-Chi, Tsai, Wan-Chi, Lin, Pai-Mei, Yang, Ming-Yu, Liu, Yi-Chang, Chang, Chao-Sung, Yu, Wen-Hui, Lin, Sheng-Fung
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2013
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3844465/
https://ncbi.nlm.nih.gov/pubmed/23941109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1423-0127-20-58
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים